250mg Gefitinib $70/bottle

Gefitinib is an EGFR inhibitor used for NSCLC. It’s especially made for people with EGFR exon 19 deletions or the L858R mutation in exon 21. Gefitinib stops EGFR signaling, which is super important for cancer cell growth.

You can get these tablets in 250 mg doses. You take them once a day, and it doesn’t matter if you eat before or after. The tablets have a coating and come in bottles with 30 in each.

The way you take it is simple. It’s made for easy use and so you’ll remember to take it. This therapy is really important for dealing with NSCLC, where it can help with targeted treatments.

It’s a big deal in medicine because it’s personalized. It targets a specific thing in cancer cells and can be used as a first treatment in some cases. People with these mutations are more likely to get NSCLC, and they do really well with gefitinib.